See All Slides - tctmd.com

Slides

Presentation TCT 2012

Case 2: FFR and Multivessel Disease

Presenter: Pim Tonino

October 25, 2012

Presentation TCT 2012

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

Presenter: Robert Lookstein

October 25, 2012

Presentation TCT 2012

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

Presenter: Clemens von Birgelen

October 25, 2012

Presentation TCT 2012

Can Any IVUS/OCT Parameters Replace FFR?

Presenter: Bon-Kwon Koo

October 25, 2012

Presentation TCT 2012

Might a Self-Expanding Stent have a Role in STEMI? Interim Results from APPOSITION III

Presenter: Harald Mudra

October 25, 2012

Presentation TCT 2012

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Presenter: Gary Mintz

October 25, 2012

Presentation TCT 2012

Dynamic Obstruction: Mechanisms and Implications for Treatment

Presenter: Carey Kimmelstiel

October 25, 2012

Presentation TCT 2012

What Is FFR, and How Is It Different from Other Indices?

Presenter: William Fearon

October 25, 2012

Presentation TCT 2012

For: The Transaortic Approach Has Clear Benefits Over the Transapical Approach!

Presenter: Vinayak Bapat

October 25, 2012

Presentation TCT 2012

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Presenter: Suhas Lele

October 25, 2012

Advertisement

Slides

Case 2: FFR and Multivessel Disease

Post-EVAR Follow-up and Imaging Surveillance: Current and Future Trends

TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents

Can Any IVUS/OCT Parameters Replace FFR?

Might a Self-Expanding Stent have a Role in STEMI? Interim Results from APPOSITION III

IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis

Dynamic Obstruction: Mechanisms and Implications for Treatment

What Is FFR, and How Is It Different from Other Indices?

For: The Transaortic Approach Has Clear Benefits Over the Transapical Approach!

First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical)

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content